OCT Imaging Tool Could Improve Diagnosis of Hearing Loss
Researchers have adapted the low-cost OCT imaging method developed for ophthalmology and used it to visualize tiny structures in the human inner ear.
Researchers have adapted the low-cost OCT imaging method developed for ophthalmology and used it to visualize tiny structures in the human inner ear.
The drug LGK974, which inhibits the Wnt signaling pathway, shows promise in reversing excessive bone growth in sclerosteosis.
Sound Pharmaceuticals' Phase 3 trial of an anti-inflammatory drug for Meniere’s disease showed significant improvements in hearing loss.
Amptify introduced a new curriculum that is designed to support individuals with unique auditory challenges.
In an article published on the ”Discover Magazine” website, author Sarah Katz challenges the view in the scientific community that deafness is a problem that needs to be cured, potentially by new CRISPR technology that could eliminate a TMC1 gene mutation.
A team of Mass Eye and Ear researchers in the Eaton-Peabody Laboratories have been awarded a five-year, $12.5 million P50 Clinical Research Center Grant from the National Institute on Deafness and Other Communicable Disorders (NIDCD) of the National Institutes of Health (NIH) to continue their research on cochlear synaptopathy, or hidden hearing loss, a type of hearing damage first discovered at Mass Eye and Ear in 2009.
Spiral Therapeutics is partnering with the Vestibular Disorders Association to improve the lives of patients suffering from balance disorders.